We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$144B
AUM Growth
+$590M
Cap. Flow
-$2.29B
Cap. Flow %
-1.6%
Top 10 Hldgs %
13.5%
Holding
3,177
New
29
Increased
1,134
Reduced
1,491
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Healthcare 15.35%
3 Financials 13.37%
4 Industrials 10.65%
5 Consumer Discretionary 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRGA
2501
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$1.23M ﹤0.01%
8,269
-232
-3% -$35.3K
SENEA icon
2502
Seneca Foods Class A
SENEA
$1.22B
$1.22M ﹤0.01%
41,070
-2,935
-7% -$79.9K
TTSH
2503
DELISTED
Tile Shop Holdings
TTSH
$1.22M ﹤0.01%
100,910
-2,783
-3% -$27.1K
PTVCB
2504
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$1.22M ﹤0.01%
52,044
+5,730
+12% +$136K
CORT icon
2505
Corcept Therapeutics
CORT
$12.3B
$1.22M ﹤0.01%
217,421
NNA
2506
DELISTED
Navios Maritime Acquisition Corporation
NNA
$1.22M ﹤0.01%
22,921
BGFV
2507
DELISTED
Big 5 Sporting Goods
BGFV
$1.21M ﹤0.01%
91,398
+2,847
+3% +$36.4K
PNX
2508
DELISTED
PHOENIX COMPANIES INC. NEW
PNX
$1.21M ﹤0.01%
24,224
-655
-3% -$39.4K
DSPG
2509
DELISTED
DSP Group Inc
DSPG
$1.21M ﹤0.01%
101,003
-2,823
-3% -$31.6K
NVEC icon
2510
NVE Corp
NVEC
$573M
$1.21M ﹤0.01%
17,548
-516
-3% -$34.3K
IXYS
2511
DELISTED
IXYS Corp
IXYS
$1.21M ﹤0.01%
98,061
-2,888
-3% -$34.5K
CRAI icon
2512
CRA International
CRAI
$1.06B
$1.21M ﹤0.01%
38,756
-1,180
-3% -$35.8K
NBBC
2513
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
$1.21M ﹤0.01%
135,099
-4,141
-3% -$35.1K
ARO
2514
DELISTED
Aeropostale Inc
ARO
$1.2M ﹤0.01%
346,298
-8,292
-2% -$26.5K
BKYF
2515
DELISTED
BK KY FINL CORP
BKYF
$1.2M ﹤0.01%
24,490
OME
2516
DELISTED
Omega Protein
OME
$1.2M ﹤0.01%
87,672
CTIC
2517
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$1.2M ﹤0.01%
66,309
+18,793
+40% +$423K
PTX
2518
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.2M ﹤0.01%
11,217
-10,710
-49% -$1.02M
OTIC
2519
DELISTED
Otonomy, Inc.
OTIC
$1.2M ﹤0.01%
33,890
+9,179
+37% +$314K
VNDA icon
2520
Vanda Pharmaceuticals
VNDA
$304M
$1.19M ﹤0.01%
128,249
-375,446
-75% -$4.24M
MG icon
2521
Mistras Group
MG
$502M
$1.19M ﹤0.01%
61,813
+1,959
+3% +$37.9K
PACB icon
2522
Pacific Biosciences
PACB
$357M
$1.19M ﹤0.01%
203,883
-3,619
-2% -$25K
RBCAA icon
2523
Republic Bancorp
RBCAA
$1.91B
$1.19M ﹤0.01%
48,176
RPRX
2524
DELISTED
Repros Therapeutics Inc.
RPRX
$1.19M ﹤0.01%
138,653
+11,842
+9% +$106K
AORT icon
2525
Artivion
AORT
$1.28B
$1.19M ﹤0.01%
114,421
-4,000
-3% -$44.1K

Similar funds

TIAA CREF Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, TIAA CREF Investment Management held 3,177 positions worth $144B, up 0.41% from $143B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 2.8%. TIAA CREF Investment Management opened 29 new positions and exited 61, leaving the 3,177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • TIAA CREF Investment Management's largest Q1 2015 buy was Columbia Pipeline Partners LP: 3,302,169 shares worth $91.4M.
  • TIAA CREF Investment Management added most to Allergan plc in Q1 2015, an estimated $397M increase.
  • TIAA CREF Investment Management's biggest Q1 2015 reduction was Microsoft, cutting an estimated $308M.
  • TIAA CREF Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $400M.
  • TIAA CREF Investment Management's ten largest holdings make up 14% of its $144B portfolio in Q1 2015.
  • TIAA CREF Investment Management opened 29 new positions and closed 61 in Q1 2015.
  • TIAA CREF Investment Management's portfolio value rose 0.41% quarter-over-quarter to $144B.

Based on TIAA CREF Investment Management's 13F filing for Q1 2015, filed 5 May 2015.